Purpose

Empower, Connect, and Grow.

Mission

We strive to focus on Research, Development, and Go-to-Market strategy of Therapeutic Products, integrating cutting-edge and digital technologies, while enhancing our commitment to ESG (Environmental, Social, and Governance).

SwAPP supports experienced professionals and newcomers in building and maintaining their network and knowledge throughout their career with key resources.

Guiding Principles

  • Empowerement
  • Connectedness
  • Growth
  • Professionalism
  • Ethics
  • Innovation

Our Story

Founded in 1995, SwAPP (Swiss Association of Pharmaceutical Professionals) emerged from a shared ambition among leading experts in the pharmaceutical industry to address the need for high-quality scientific training supporting specialists in the field. From the outset, the vision of SwAPP was to enhance the quality of specialised education, helping professionals stay up to date and ensure the compliance of therapeutic products for the safety and benefit of patients.

Key milestones included:

  • The creation of SwAPP Diplomas in Pharmaceutical Medicine, Regulatory Affairs, Clinical Pharmacology, Study Management, Medical Marketing and GCP Quality Management, establishing recognised certifications that support lifelong learning education for experienced professionals.
  • The development and implementation of an eLearning tool for online GCP training and certification, later out-licensed to a dedicated non-profit organisation.
  • The launch of the Experts Exchange Expertise (ExEx) in 2008—an event combining plenary sessions, panel discussions and workshops with hands‑on perspectives from industry, academia and regulatory bodies.
  • In the early 2010s, the full integration of Medical Devices into SwAPP’s scope, reflecting the evolving landscape of therapeutic products and the corresponding regulatory requirements.

Over the years, the association has grown into a recognised partner within the Swiss healthcare ecosystem, and SwAPP events have quickly become well-established reference points for educational and networking among professionals involved in therapeutic product development.

In 2024, SwAPP defined a new strategy aimed at strengthening the association and adapting its activities and offerings to today’s professional challenges and emerging needs. This comprehensive review led to an in‑depth transformation and substantial organisational updates, formalised through new bylaws adopted by the General Assembly in 2025.

Today, SwAPP continues to be a key actor within the Swiss ecosystem, supporting the continuous professional development and career growth of its members. By increasing and diversifying its activities, SwAPP is expanding steadily, bringing together a growing community of professionals from Pharma, Biotech & Medtech companies, contract research organisations, consulting and service providers, academia, healthcare institutions, health or other competent authorities, ethics committees and any other related entity.